Tuesday, March 28, 2023
Disclosure
The Heart Failure Society of America (HFSA) is committed to fair and balanced educational content that is independent of industry influence. Participants are ensured objectivity and scientific rigor in all continuing education (CE) activities, free from the appearance of or actual conflicts of interest (COI).
It is the policy of the Heart Failure Society of America (HFSA) that all individuals who serve on a committee or in any position to influence the content of a certified CE activity must disclose all financial relationships with any ineligible companies that have occurred over the past 24 months.
An ineligible company is defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; all financial relationships, regardless of the amount, with ineligible companies must be disclosed.
All potential conflicts of interests have been resolved in accordance with the Joint Accreditation Standards for Integrity and Independence in Accredited Continuing Education.
Cardiologist
Meyer Friedman Distinguished Professor of Medicine
Director, UCSF Adult Cardiac Echocardiography Laboratory
University of California San Francisco
San Francisco, California
Assistant Professor
Inherited Cardiomyopathy Program
Frankel Cardiovascular Center
University of Michigan Hospital Michigan Medicine
Ann Arbor, Michigan
Associate Professor of Medicine
Hospital of the University of Pennsylvania
Director, Penn Familial Cardiomyopathy Program
Director, Penn Center for Inherited Cardiovascular Disease
University of Pennsylvania
Philadelphia, Pennsylvania
Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™
Nurses - 1.25 ANCC Contact Hour(s) (1.25 contact hours are in the area of pharmacology)
Pharmacists - 1.25 Knowledge-based ACPE (0.125 CEUs)
This activity is intended for cardiologists, primary care physicians, surgeons, nurses/nurse practitioners, and pharmacists.
The goal of this activity is for learners to be better able to improve knowledge of emerging cardiac myosin inhibitor therapy, the latest clinical data for cardiac myosin inhibitor therapies that target the underlying sarcomere dysfunction in HCM, and how to integrate this new evidence into clinical practice for appropriate patients.
Upon completion of this activity, participants will:
Disclosure
The Heart Failure Society of America (HFSA) is committed to fair and balanced educational content that is independent of industry influence. Participants are ensured objectivity and scientific rigor in all continuing education (CE) activities, free from the appearance of or actual conflicts of interest (COI).
It is the policy of the Heart Failure Society of America (HFSA) that all individuals who serve on a committee or in any position to influence the content of a certified CE activity must disclose all financial relationships with any ineligible companies that have occurred over the past 24 months.
An ineligible company is defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; all financial relationships, regardless of the amount, with ineligible companies must be disclosed.
All potential conflicts of interests have been resolved in accordance with the Joint Accreditation Standards for Integrity and Independence in Accredited Continuing Education.
Cardiologist
Meyer Friedman Distinguished Professor of Medicine
Director, UCSF Adult Cardiac Echocardiography Laboratory
University of California San Francisco
San Francisco, California
Assistant Professor
Inherited Cardiomyopathy Program
Frankel Cardiovascular Center
University of Michigan Hospital Michigan Medicine
Ann Arbor, Michigan
Associate Professor of Medicine
Hospital of the University of Pennsylvania
Director, Penn Familial Cardiomyopathy Program
Director, Penn Center for Inherited Cardiovascular Disease
University of Pennsylvania
Philadelphia, Pennsylvania
The Heart Failure Society of America designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity includes participation in the evaluation component and post-test.
This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America. This activity is approved for a maximum 1.25 contact hours. Learners should claim only the credit commensurate with the extent of their participation in the activity.
The Heart Failure Society of America is an accredited provider of continuing pharmacy education (CPE). This event is accredited for up to 1.25 contact hours of knowledge-based CPE. ACPE Universal Activity Numbers (UAN): JA4008267-0000-22-017-H04-P.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 11/3/2022
Valid for credit through: 11/3/2023
processing....
Please answer these questions to complement your learning experience.
